Where do we invest?

Our Portfolio

Black Light Surgical

Black Light Surgical (BLS), Inc. has developed a medical device that has shown a very high level of sensitivity and specificity in determining in a matter of seconds whether a brain lesion is benign or cancerous, and can provide tools to aid surgeons in achieving complete resection of tumors.  

BLS will primarily focus on use of optical technologies to provide intra-operative real-time diagnostic information to surgeons. The technology is now being developed to apply to dermatologic, breast and other lesions.

Fortem Neurosciences

Developed at Cedars-Sinai, Fortem Neurosciences, Inc. has 3 platform technologies for the treatment of Alzheimer’s and dementia.

This year, Alzheimer’s and other dementias will cost the nation an estimated $230 billion. By 2050, that number could rise to more than $1 trillion.


TruVerse, Inc. is an AI powered conversation platform for businesses. Proprietary technology enables marketers and enterprises to generate real conversations and actionable outcomes using the TruVerse platform.
Combination of machine learning and human experts to continuously grow more intelligent and optimize every conversation.
Platform allows hyper-segmentation and can plug directly into a company’s CRM or DMP systems.

Vault Pharma

Vault Nano, Inc. d.b.a. Vault Pharma is a therapeutic drug company with a technology platform based on the vault particle discovered in a UCLA lab.

    Applications include:
  • Cancer therapeutics
  • Anti-cancer vaccine
  • Immune therapeutics
  • Immune Oncology
  • Therapeutic Vault Vaccines

The holdings identified do not represent all of the securities purchased, sold, or recommended for the Fund. It should not be assumed that recommendations made in the past or the future will be profitable. Past performance does not guarantee future results.